Bumetanide
Bumetanide
13 active makers
soon
soon
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it13 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | unknown | 4 | SUPPLYING |
| Novadoz Pharmaceuticals LLC | unknown | 2 | SUPPLYING |
| Civica, Inc. | unknown | 2 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 2 | SUPPLYING |
| Mullan Pharmaceutical Inc. | unknown | 2 | SUPPLYING |
| Qilu Pharmaceutical Co. Ltd. | unknown | 2 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | unknown | 2 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 2 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | unknown | 2 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 2 | SUPPLYING |
| Cardinal Health 107, LLC | unknown | 2 | SUPPLYING |
| Gland Pharma Limited | unknown | 2 | SUPPLYING |
| HF Acquisition Co LLC, DBA HealthFirst | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jan 31, 2018SHORTAGEDrug shortage: Bumetanide Injection (Hikma Pharmaceuticals USA, Inc.)
Bumetanide Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Cardiovascular.
- Jan 31, 2018SHORTAGEDrug shortage: Bumetanide Injection (Fresenius Kabi USA, LLC)
Bumetanide Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Cardiovascular.
- Dec 13, 2017SHORTAGEDrug shortage: Bumetanide Injection (MSN Laboratories Private Limited)
Bumetanide Injection — reported in shortage by MSN Laboratories Private Limited. Therapeutic category: Cardiovascular.
- Dec 13, 2017SHORTAGEDrug shortage: Bumetanide Injection (Mullan Pharmaceutical Inc.)
Bumetanide Injection — reported in shortage by Mullan Pharmaceutical Inc.. Therapeutic category: Cardiovascular.
Pill